Loo uus konto

Registreeru ning avasta:
  • Personaalsed erihinnad
  • Tellimuse staatuse info
  • Eeltäidetud ja kiire tellimuse vormistamine
  • Tellimuste ajalugu ning mugav kordustellimine
  • Nähtav toodete laoseis
Cart

Sinu ostukorv on tühi, lisa mõni toode

Kui e-poes sobivat toodet ei leidu, siis meie tootejuhid on hea meelega valmis aitama, küsi julgelt!

Tarne

0,00 €

Kokku: 0,00 €

image/svg+xml +372 5656 0050, +370 (620) 70159
image/svg+xml Sisene / Registreeru
Sisene või registreeru
Sisene Loo konto
Registreeru ning avasta:
  • Personaalsed erihinnad
  • Tellimuse staatuse info
  • Eeltäidetud ja kiire tellimuse vormistamine
  • Tellimuste ajalugu ning mugav kordustellimine
  • Nähtav toodete laoseis
1-placeholder

Tootekood 119232

Yersinia enterocolitica - Xen24 bioluminescent pathogenic bacteria for in vivo and in vitro drug discovery. This product was derived from the 91A1854 clinical isolate. Y. enterocolitica-Xen24 possesses a stable copy of the Photorhabdus luminescens lux operon on the bacterial chromosome. Infectious disease is a perennially important area for both life science research and drug discovery. Some of the first applications of IVIS® imaging technology were in tracking infections and monitoring host responses, and these applications are still at the forefront of research. PerkinElmer's bioluminescent infectious disease light-producing microorganisms have been developed to mimic both acute and chronic standard infection protocols presently used by researchers. · Engineered Bacterium: Yersinia enterocolitica - Xen24 · Parental Strain: 91A1854 clinical isolate · In Vitro/Ex Vivo: Growth profiles · In Vivo: Not tested Advantages of using bioluminescent light-producing microorganisms for drug discovery in vitro: · Rapid and readily amenable to high throughput screening, e.g., 96 or 384-well format · Sensitivity - subtle changes in cellular viability are rapidly detected · Inexpensive - no additional substrates needed for bacterial assays Advantages of using bioluminescent light-producing microorganisms for drug discovery in vivo: · Rapid identification of lead drug candidates · Real-time efficacy data · May help to decrease drug failure by allowing disease relapse to be monitored in the same animal For laboratory use only. This product is intended for animal research only and not for use in humans.

Spetsifikatsioonid

Spetsifikatsioonid

Dokumendid

In_Vivo_Agents.pdf

Perkin Elmer In Vivo Imaging Agents Brochure

EN | 4,238 MB

Download

Hiljuti vaadatud

Kontakt

Nova Natura UAB

Chemijos G. 11, LT-51347,
Kaunas, Lithuania

nova@novabio.lt
Phone: +370 (620) 70159

Reg No 305063819

Nova Natura OÜ

Kanali tee 6, 10112,
Tallinn, Estonia

nova@novabio.ee
Phone: +372 5656 0050

Reg No 14758203

NOVA uudiskiri

Certification9001